MannKind (MNKD) Misses Q3 EPS by 11c
Get Alerts MNKD Hot Sheet
Price: $4.16 +2.46%
Revenue Growth %: +34.2%
Financial Fact:
Net loss: 126.52M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +34.2%
Financial Fact:
Net loss: 126.52M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
MannKind (NASDAQ: MNKD) reported Q3 EPS of ($0.31), $0.11 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $2 million versus the consensus estimate of $3.88 million.
- Afrezza net revenue grew 28% and 246% vs. 2Q 2017 and 3Q 2016, respectively
- Cash burn of $23.3 million in 3Q 2017
- Exchanged all outstanding Series A and B Common Stock Warrants for an aggregate of 1.3 million shares of the Company’s common stock
- FDA approved label changes for Afrezza
For earnings history and earnings-related data on MannKind (MNKD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Mission Produce (AVO) Misses Q3 EPS by 2c; offers outlook
- GameStop (GME) Tops Q2 EPS by 8c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share